Although overexpressed IGFBP-2 is associated with increased tumor stages and grades (12), relapse, metastasis (14) and prognosis (16) in advanced cancers, it is less satisfactory in diagnosing early cancers. The gene discussed is IGFBP2; the disease is cancer.